Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Now accepting nominations for the Fierce Innovation Awards - Submit your application today
antibody-drug conjugates
Pharma
GSK-Hansoh, Merck-Kelun, AZ-Dizal—Fierce Pharma Asia
Kelun and Hansoh reported positive phase 3s for their Big Pharma-partnered ADCs. AZ buys an EGFR lung cancer med from its spinout Dizal. And more.
Angus Liu
Jul 17, 2026 9:38am
Kelun's sac-TMT win offers blueprint for Merck's global gap
Jul 15, 2026 10:20am
FDA expands Padcev-Keytruda combo to more MIBC patients
Jul 10, 2026 1:10pm
BioNTech lays commercial groundwork for PD-L1xVEGF via HER2 ADC
Jul 9, 2026 2:17pm
Lonza to expand ADC capacity, broaden collab with US drugmaker
Jul 1, 2026 3:22pm
Gilead’s Trodelvy nabs broad FDA approval in front-line TNBC
Jun 24, 2026 5:00pm
